Palisade Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
Palisade Bio (NASDAQ:PALI), a clinical-stage biopharmaceutical company developing therapeutics for autoimmune, inflammatory, and fibrotic diseases, announced its participation in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference.
During the conference, CEO JD Finley shared insights about his career journey, his commitment to the company, and his enthusiasm for Palisade's development programs. The presentation is now accessible on-demand through virtualinvestorco.com and the company's investor relations website.
Palisade Bio (NASDAQ:PALI), una società biofarmaceutica in fase clinica che sviluppa terapie per malattie autoimmuni, infiammatorie e fibrotiche, ha annunciato la sua partecipazione alla conferenza virtuale per investitori "What's Your Story" Summer Spotlight On-Demand.
Durante la conferenza, il CEO JD Finley ha condiviso riflessioni sul suo percorso professionale, il suo impegno verso l'azienda e il suo entusiasmo per i programmi di sviluppo di Palisade. La presentazione è ora disponibile on-demand su virtualinvestorco.com e sul sito web delle relazioni con gli investitori della società.
Palisade Bio (NASDAQ:PALI), una compañía biofarmacéutica en etapa clínica que desarrolla terapias para enfermedades autoinmunes, inflamatorias y fibróticas, anunció su participación en la conferencia virtual para inversores "What's Your Story" Summer Spotlight On-Demand.
Durante la conferencia, el CEO JD Finley compartió detalles sobre su trayectoria profesional, su compromiso con la empresa y su entusiasmo por los programas de desarrollo de Palisade. La presentación ya está disponible bajo demanda en virtualinvestorco.com y en el sitio web de relaciones con inversores de la compañía.
Palisade Bio (NASDAQ:PALI)는 자가면역, 염증 및 섬유증 질환 치료제를 개발하는 임상 단계 바이오제약 회사로서, 가상 투자자 "What's Your Story" 여름 스포트라이트 온디맨드 컨퍼런스에 참여했다고 발표했습니다.
컨퍼런스에서 CEO JD Finley는 자신의 경력 여정, 회사에 대한 헌신, 그리고 Palisade의 개발 프로그램에 대한 열정을 공유했습니다. 해당 발표는 현재 virtualinvestorco.com과 회사 투자자 관계 웹사이트에서 온디맨드로 시청할 수 있습니다.
Palisade Bio (NASDAQ:PALI), une société biopharmaceutique en phase clinique développant des traitements pour les maladies auto-immunes, inflammatoires et fibrosantes, a annoncé sa participation à la conférence virtuelle pour investisseurs "What's Your Story" Summer Spotlight On-Demand.
Lors de la conférence, le PDG JD Finley a partagé des informations sur son parcours professionnel, son engagement envers l'entreprise et son enthousiasme pour les programmes de développement de Palisade. La présentation est désormais accessible à la demande sur virtualinvestorco.com et le site des relations investisseurs de la société.
Palisade Bio (NASDAQ:PALI), ein biopharmazeutisches Unternehmen in der klinischen Phase, das Therapeutika für Autoimmun-, Entzündungs- und Fibroseerkrankungen entwickelt, gab seine Teilnahme an der virtuellen Investorenkonferenz "What's Your Story" Summer Spotlight On-Demand bekannt.
Während der Konferenz teilte CEO JD Finley Einblicke in seinen beruflichen Werdegang, sein Engagement für das Unternehmen und seine Begeisterung für die Entwicklungsprogramme von Palisade. Die Präsentation ist jetzt auf Abruf über virtualinvestorco.com und die Investor-Relations-Website des Unternehmens verfügbar.
- None.
- None.
– Video webcast now available on-demand
Carlsbad, CA, July 22, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced JD Finley Chief Executive Officer of Palisade Bio, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.
As part of the event, Mr. Finley dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s programs in development.
The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page under the Investors section of the Company’s website (palisadebio.com).
About Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.
Investor Relations Contact
JTC Team, LLC
Jenene Thomas
908-824-0775
PALI@jtcir.com
FAQ
When did Palisade Bio (PALI) participate in the Virtual Investor Summer Spotlight Conference?
What therapeutic areas does Palisade Bio (PALI) focus on?
Who is the CEO of Palisade Bio (PALI)?
Where can investors watch Palisade Bio's (PALI) conference presentation?
